Naturally Occurring Human Genetic Variation in the 3′-Untranslated Region of the Secretory Protein Chromogranin A Is Associated With Autonomic Blood Pressure Regulation and Hypertension in a Sex-Dependent Fashion

Journal of the American College of Cardiology

Volumn 52, Issue 18, 2008, Pages 1468-1481

  Chen, Yuqing ^a,f   Rao, Fangwen ^a   Rodriguez Flores, Juan L ^a   Mahata, Manjula ^a   Fung, Maple M ^a   Stridsberg, Mats ^e   Vaingankar, Sucheta M ^a   Wen, Gen ^a   Salem, Rany M ^a   Das, Madhusudan ^a   Cockburn, Myles G ^d   Schork, Nicholas J ^b   Ziegler, Michael G ^a   Hamilton, Bruce A ^a   Mahata, Sushil K ^a,c   Taupenot, Laurent ^a   O'Connor, Daniel T ^a,b,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UPPSALA UNIVERSITY   (Sweden)

^f PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

adrenal; catecholamine; chromaffin; hypertension; sympathetic

Indexed keywords

CATECHOLAMINE; CHROMOGRANIN A; DNA; MESSENGER RNA; SMALL INTERFERING RNA;

3' UNTRANSLATED REGION; ADOLESCENT; ADULT; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BLOOD PRESSURE REGULATION; CASE CONTROL STUDY; CATECHOLAMINE RELEASE; CELL CULTURE; CHROMAFFIN CELL; COLD STRESS; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HERITABILITY; HUMAN; HUMAN CELL; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE TRAIT; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TWINS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; CATECHOLAMINES; CHROMOGRANIN A; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PHENOTYPE; PILOT PROJECTS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEX FACTORS; TWINS; YOUNG ADULT;

EID: 53949122279     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.07.047     Document Type: Article

References (74)

1. Taupenot L., Harper K.L., and O'Connor D.T. The chromogranin-secretogranin family. N Engl J Med 348 (2003) 1134-1149
2. Winkler H., and Fischer-Colbrie R. The chromogranins A and B: the first 25 years and future perspectives. Neuroscience 49 (1992) 497-528
3. Takiyyuddin M.A., Cervenka J.H., Sullivan P.A., et al. Is physiologic sympathoadrenal catecholamine release exocytotic in humans?. Circulation 81 (1990) 185-195
4. Videen J.S., Mezger M.S., Chang Y.M., and O'Connor D.T. Calcium and catecholamine interactions with adrenal chromogranins. Comparison of driving forces in binding and aggregation. J Biol Chem 267 (1992) 3066-3073
5. Yoo S.H., So S.H., Huh Y.H., and Park H.Y. Inositol 1,4,5-trisphosphate receptor/Ca(2+) channel modulatory role of chromogranins A and B. Ann N Y Acad Sci 971 (2002) 300-310
6. Kim T., Tao-Cheng J.H., Eiden L.E., and Loh Y.P. Chromogranin A, an "on/off" switch controlling dense-core secretory granule biogenesis. Cell 106 (2001) 499-509
7. Cadman P.E., Rao F., Mahata S.K., and O'Connor D.T. Studies of the dysglycemic peptide, pancreastatin, using a human forearm model. Ann N Y Acad Sci 971 (2002) 528-529
8. Tatemoto K., Efendic S., Mutt V., Makk G., Feistner G.J., and Barchas J.D. Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature 324 (1986) 476-478
9. Strub J.M., Goumon Y., Lugardon K., et al. Antibacterial activity of glycosylated and phosphorylated chromogranin A-derived peptide 173-194 from bovine adrenal medullary chromaffin granules. J Biol Chem 271 (1996) 28533-28540
10. Aardal S., Helle K.B., Elsayed S., Reed R.K., and Serck-Hanssen G. Vasostatins, comprising the N-terminal domain of chromogranin A, suppress tension in isolated human blood vessel segments. J Neuroendocrinol 5 (1993) 405-412
11. Mahata S.K., Mahata M., Parmer R.J., and O'Connor D.T. Desensitization of catecholamine release. The novel catecholamine release-inhibitory peptide catestatin (chromogranin a344-364) acts at the receptor to prevent nicotinic cholinergic tolerance. J Biol Chem 274 (1999) 2920-2928
12. Mahata S.K., O'Connor D.T., Mahata M., et al. Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist. J Clin Invest 100 (1997) 1623-1633
13. Lander E.S., and Schork N.J. Genetic dissection of complex traits. Science 265 (1994) 2037-2048
14. Hsiao R.J., Parmer R.J., Takiyyuddin M.A., and O'Connor D.T. Chromogranin A storage and secretion: sensitivity and specificity for the diagnosis of pheochromocytoma. Medicine (Baltimore) 70 (1991) 33-45
15. O'Connor D.T. Plasma chromogranin A. Initial studies in human hypertension. Hypertension 7 (1985) I76-I79
16. Takiyyuddin M.A., Cervenka J.H., Hsiao R.J., Barbosa J.A., Parmer R.J., and O'Connor D.T. Chromogranin A. Storage and release in hypertension. Hypertension 15 (1990) 237-246
17. Takiyyuddin M.A., Parmer R.J., Kailasam M.T., et al. Chromogranin A in human hypertension. Influence of heredity. Hypertension 26 (1995) 213-220
18. O'Connor D.T., Takiyyuddin M.A., Printz M.P., et al. Catecholamine storage vesicle protein expression in genetic hypertension. Blood Press 8 (1999) 285-295
19. Dimsdale J.E., O'Connor D.T., Ziegler M., and Mills P. Chromogranin A correlates with norepinephrine release rate. Life Sci 51 (1992) 519-525
20. Mahapatra N.R., O'Connor D.T., Vaingankar S.M., et al. Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog. J Clin Invest 115 (2005) 1942-1952
21. Wen G., Mahata S.K., Cadman P., et al. Both rare and common polymorphisms contribute functional variation at CHGA, a regulator of catecholamine physiology. Am J Hum Genet 74 (2004) 197-207
22. Brinton T.J., Cotter B., Kailasam M.T., et al. Development and validation of a noninvasive method to determine arterial pressure and vascular compliance. Am J Cardiol 80 (1997) 323-330
23. Rana B.K., Insel P.A., Payne S.H., et al. Population-based sample reveals gene-gender interactions in blood pressure in white Americans. Hypertension 49 (2007) 96-106
24. Waalen J., Felitti V., Gelbart T., Ho N.J., and Beutler E. Prevalence of coronary heart disease associated with HFE mutations in adults attending a health appraisal center. Am J Med 113 (2002) 472-479
25. Seasholtz T.M., Wessel J., Rao F., et al. Rho kinase polymorphism influences blood pressure and systemic vascular resistance in human twins: role of heredity. Hypertension 47 (2006) 937-947
26. Purcell S., Cherny S.S., and Sham P.C. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19 (2003) 149-150
27. Schork N.J., Nath S.K., Fallin D., and Chakravarti A. Linkage disequilibrium analysis of biallelic DNA markers, human quantitative trait loci, and threshold-defined case and control subjects. Am J Hum Genet 67 (2000) 1208-1218
28. Zhang L., Rao F., Wessel J., et al. Functional allelic heterogeneity and pleiotropy of a repeat polymorphism in tyrosine hydroxylase: prediction of catecholamines and response to stress in twins. Physiol Genomics 19 (2004) 277-291
29. Greenwood T.A., Rao F., Stridsberg M., et al. Pleiotropic effects of novel trans-acting loci influencing human sympathochromaffin secretion. Physiol Genomics 25 (2006) 470-479
30. Wessel J., Moratorio G., Rao F., et al. C-reactive protein, an 'intermediate phenotype' for inflammation: human twin studies reveal heritability, association with blood pressure and the metabolic syndrome, and the influence of common polymorphism at catecholaminergic/beta-adrenergic pathway loci. J Hypertens 25 (2007) 329-343
31. O'Connor D.T., Kailasam M.T., Kennedy B.P., Ziegler M.G., Yanaihara N., and Parmer R.J. Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension. J Hypertens 20 (2002) 1335-1345
32. Lafleche A.B., Pannier B.M., Laloux B., and Safar M.E. Arterial response during cold pressor test in borderline hypertension. Am J Physiol 275 (1998) H409-H415
33. Kasagi F., Akahoshi M., and Shimaoka K. Relation between cold pressor test and development of hypertension based on 28-year follow-up. Hypertension 25 (1995) 71-76
34. Stridsberg M. Measurements of chromogranins and chromogranin-related peptides by immunological methods. Adv Exp Med Biol 482 (2000) 319-327
35. Stridsberg M., Angeletti R.H., and Helle K.B. Characterisation of N-terminal chromogranin A and chromogranin B in mammals by region-specific radioimmunoassays and chromatographic separation methods. J Endocrinol 165 (2000) 703-714
36. Stridsberg M., Oberg K., Li Q., Engstrom U., and Lundqvist G. Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours. J Endocrinol 144 (1995) 49-59
37. Kennedy B., and Ziegler M.G. A more sensitive and specific radioenzymatic assay for catecholamines. Life Sci 47 (1990) 2143-2153
38. Herrmann V., Buscher R., Go M.M., et al. Beta2-adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in whites and African Americans. Am J Hypertens 13 (2000) 1021-1026
39. Buetow K.H., Edmonson M., MacDonald R., et al. High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc Natl Acad Sci U S A 98 (2001) 581-584
40. Ahmadian A., Ehn M., and Hober S. Pyrosequencing: history, biochemistry and future. Clin Chim Acta 363 (2006) 83-94
41. Greene L.A., and Tischler A.S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A 73 (1976) 2424-2428
42. Abecasis G.R., and Cookson W.O. GOLD-graphical overview of linkage disequilibrium. Bioinformatics 16 (2000) 182-183
43. Fallin D., Cohen A., Essioux L., et al. Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer's disease. Genome Res 11 (2001) 143-151
44. Zaykin D.V., Westfall P.H., Young S.S., Karnoub M.A., Wagner M.J., and Ehm M.G. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 53 (2002) 79-91
45. Halperin E., and Eskin E. Haplotype reconstruction from genotype data using imperfect phylogeny. Bioinformatics 20 (2004) 1842-1849
46. Clarkson D., Fan Y.-A., and Joe H. A remark on algorithm 643: FEXACT: an algorithm for performing Fisher's exact test in R×C contingency tables. ACM Transactions on Mathematical Software 19 (1993) 484-488
47. Nyholt D.R. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74 (2004) 765-769
48. Simes R.J. An improved Bonferroni procedure for multiple test of significance. Biometrika 73 (1986) 751-754
49. Benjamini Y., and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodological) 57 (1995) 289-300
50. Almasy L., and Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62 (1998) 1198-1211
51. Do K.A., Broom B.M., Kuhnert P., et al. Genetic analysis of the age at menopause by using estimating equations and Bayesian random effects models. Stat Med 19 (2000) 1217-1235
52. Huang H.Y., Chien C.H., Jen K.H., and Huang H.D. RegRNA: an integrated web server for identifying regulatory RNA motifs and elements. Nucleic Acids Res 34 (2006) W429-W434
53. Mathews D.H., Sabina J., Zuker M., and Turner D.H. Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J Mol Biol 288 (1999) 911-940
54. Schork N.J., Gardner J.P., Zhang L., et al. Genomic association/linkage of sodium lithium countertransport in CEPH pedigrees. Hypertension 40 (2002) 619-628
55. Folkow B. Physiological aspects of primary hypertension. Physiol Rev 62 (1982) 347-504
56. Excoffier L., Novembre J., and Schneider S. SIMCOAL: a general coalescent program for the simulation of molecular data in interconnected populations with arbitrary demography. J Hered 91 (2000) 506-509
57. King D., Etzel J.P., Chopra S., et al. Human response to alpha2-adrenergic agonist stimulation studied in an isolated vascular bed in vivo: biphasic influence of dose, age, gender, and receptor genotype. Clin Pharmacol Ther 77 (2005) 388-403
58. Kneale B.J., Chowienczyk P.J., Brett S.E., Coltart D.J., and Ritter J.M. Gender differences in sensitivity to adrenergic agonists of forearm resistance vasculature. J Am Coll Cardiol 36 (2000) 1233-1238
59. Markovitz J.H., Raczynski J.M., Wallace D., Chettur V., and Chesney M.A. Cardiovascular reactivity to video game predicts subsequent blood pressure increases in young men: the CARDIA study. Psychosom Med 60 (1998) 186-191
60. Dubey R.K., Oparil S., Imthurn B., and Jackson E.K. Sex hormones and hypertension. Cardiovasc Res 53 (2002) 688-708
61. Liu P.Y., Death A.K., and Handelsman D.J. Androgens and cardiovascular disease. Endocr Rev 24 (2003) 313-340
62. Menkes M.S., Matthews K.A., Krantz D.S., et al. Cardiovascular reactivity to the cold pressor test as a predictor of hypertension. Hypertension 14 (1989) 524-530
63. Reckelhoff J.F. Gender differences in the regulation of blood pressure. Hypertension 37 (2001) 1199-1208
64. Schneider G.M., Jacobs D.W., Gevirtz R.N., and O'Connor D.T. Cardiovascular haemodynamic response to repeated mental stress in normotensive subjects at genetic risk of hypertension: evidence of enhanced reactivity, blunted adaptation, and delayed recovery. J Hum Hypertens 17 (2003) 829-840
65. Snieder H., Harshfield G.A., Barbeau P., Pollock D.M., Pollock J.S., and Treiber F.A. Dissecting the genetic architecture of the cardiovascular and renal stress response. Biol Psychol 61 (2002) 73-95
66. Schork N.J., Fallin D., Thiel B., et al. The future of genetic case-control studies. Adv Genet 42 (2001) 191-212
67. Lillie E.O., and O'Connor D.T. Early phenotypic changes in hypertension: a role for the autonomic nervous system and heredity. Hypertension 47 (2006) 331-333
68. Treiber F.A., Kamarck T., Schneiderman N., Sheffield D., Kapuku G., and Taylor T. Cardiovascular reactivity and development of preclinical and clinical disease states. Psychosom Med 65 (2003) 46-62
69. O'Connor D.T., Insel P.A., Ziegler M.G., et al. Heredity and the autonomic nervous system in human hypertension. Curr Hypertens Rep 2 (2000) 16-22
70. Barreau C., Paillard L., and Osborne H.B. AU-rich elements and associated factors: are there unifying principles?. Nucleic Acids Res 33 (2005) 7138-7150
71. Huh Y.H., Jeon S.H., and Yoo S.H. Chromogranin B-induced secretory granule biogenesis: comparison with the similar role of chromogranin A. J Biol Chem 278 (2003) 40581-40589
72. Takiyyuddin M.A., Brown M.R., Dinh T.Q., et al. Sympatho-adrenal secretion in humans: factors governing catecholamine and storage vesicle peptide co-release. J Auton Pharmacol 14 (1994) 187-200
73. Parmer R.J., and O'Connor D.T. Enkephalins in human phaeochromocytomas: localization in immunoreactive, high molecular weight form to the soluble core of chromaffin granules. J Hypertens 6 (1988) 187-198
74. Reich D.E., and Lander E.S. On the allelic spectrum of human disease. Trends Genet 17 (2001) 502-510